Simulations Plus Net Income 2010-2025 | SLP
Simulations Plus net income from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Simulations Plus Annual Net Income
(Millions of US $) |
| 2024 |
$10 |
| 2023 |
$10 |
| 2022 |
$12 |
| 2021 |
$10 |
| 2020 |
$9 |
| 2019 |
$9 |
| 2018 |
$9 |
| 2017 |
$6 |
| 2016 |
$5 |
| 2015 |
$4 |
| 2014 |
$3 |
| 2013 |
$3 |
| 2012 |
$3 |
| 2011 |
$3 |
| 2010 |
$2 |
| 2009 |
$1 |
Simulations Plus Quarterly Net Income
(Millions of US $) |
| 2025-02-28 |
$3 |
| 2024-11-30 |
$0 |
| 2024-08-31 |
$1 |
| 2024-05-31 |
$3 |
| 2024-02-29 |
$4 |
| 2023-11-30 |
$2 |
| 2023-08-31 |
$1 |
| 2023-05-31 |
$4 |
| 2023-02-28 |
$4 |
| 2022-11-30 |
$1 |
| 2022-08-31 |
$1 |
| 2022-05-31 |
$4 |
| 2022-02-28 |
$4 |
| 2021-11-30 |
$3 |
| 2021-08-31 |
$0 |
| 2021-05-31 |
$4 |
| 2021-02-28 |
$3 |
| 2020-11-30 |
$2 |
| 2020-08-31 |
$2 |
| 2020-05-31 |
$3 |
| 2020-02-29 |
$2 |
| 2019-11-30 |
$2 |
| 2019-08-31 |
$2 |
| 2019-05-31 |
$3 |
| 2019-02-28 |
$2 |
| 2018-11-30 |
$2 |
| 2018-08-31 |
$1 |
| 2018-05-31 |
$2 |
| 2018-02-28 |
$3 |
| 2017-11-30 |
$2 |
| 2017-08-31 |
$1 |
| 2017-05-31 |
$2 |
| 2017-02-28 |
$1 |
| 2016-11-30 |
$1 |
| 2016-08-31 |
$1 |
| 2016-05-31 |
$2 |
| 2016-02-29 |
$1 |
| 2015-11-30 |
$1 |
| 2015-08-31 |
$0 |
| 2015-05-31 |
$2 |
| 2015-02-28 |
$1 |
| 2014-11-30 |
$1 |
| 2014-08-31 |
$0 |
| 2014-05-31 |
$1 |
| 2014-02-28 |
$1 |
| 2013-11-30 |
$1 |
| 2013-08-31 |
$0 |
| 2013-05-31 |
$1 |
| 2013-02-28 |
$1 |
| 2012-11-30 |
$1 |
| 2012-08-31 |
$0 |
| 2012-05-31 |
$1 |
| 2012-02-29 |
$1 |
| 2011-11-30 |
$1 |
| 2011-08-31 |
$0 |
| 2011-05-31 |
$1 |
| 2011-02-28 |
$1 |
| 2010-11-30 |
$1 |
| 2010-08-31 |
$0 |
| 2010-05-31 |
$1 |
| 2010-02-28 |
$1 |
| 2009-11-30 |
$0 |
| 2009-08-31 |
$0 |
| 2009-05-31 |
$1 |
| 2009-02-28 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.384B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
